Table 5.

Treatment and follow-up outcomes of 272 MDR spinal TB patients in this study

Treatment	ESR (mm/h)	VAS	ASIA (N)
			A	B	C	D	E
Only chemotherapy (N = 106)
Prior treatment	51.41 ± 23.42	5.46 ± 1.76	0	0	2	8	96
Final follow-up	5.93 ± 3.22*	1.04 ± 0.98*	0	0	0	5	101*
Chemotherapy + anterior approach (N = 39)
Pre-operation	48.13 ± 27.45	5.71 ± 1.58	2	1	2	7	27
3 months postoperative	6.93 ± 4.42*	2.44 ± 0.78*	0	0	2	1	36*
Final follow-up	5.29 ± 3.03Δ	0.47 ± 0.63Δ	0	0	1	1	37
Chemotherapy + posterior approach (N = 68)
Pre-operation	50.53 ± 25.98	5.89 ± 1.68	3	0	7	25	33
3 months postoperative	7.09 ± 4.23*	2.66 ± 0.95*	0	1	3	10	54*
Final follow-up	5.88 ± 2.93Δ	0.61 ± 0.63Δ	0	0	2	2	64Δ
Chemotherapy + combined approach (N = 52)
Pre-operation	46.79 ± 22.26	5.88 ± 1.91	5	0	5	16	26
3 months postoperative	6.62 ± 4.61*	2.67 ± 0.91*	0	0	5	2	45*
Final follow-up	5.71 ± 1.58	0.48 ± 0.60Δ	0	0	4	1	47
Chemotherapy + CT guided puncture (N = 7)
Pre-operation	52.46 ± 25.34	5.88 ± 1.91	0	0	0	3	4
3 months postoperative	7.14 ± 3.81*	1.67 ± 0.79*	0	0	0	1	6*
Final follow-up	6.22 ± 4.11	1.27 ± 0.65	0	0	0	0	7

ESR: erythrocyte sedimentation rate, VAS: Visual Analogue Scale, ASIA: American Spinal Injury Association grading.

*P < 0.05 vs. pre-operation or prior treatment.

ΔP < 0.05 vs. 3 months postoperative.